Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use? - Poll - MDSpire

Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use?

  • By

  • Margarete Teresa Walach

  • Ralph Burger

  • Felix Brumm

  • Katja Nitschke

  • Frederik Wessels

  • Philipp Nuhn

  • Thomas Stephan Worst

  • Jost von Hardenberg

  • Britta Grüne

  • Jonas Jarczyk

  • January 29, 2025

  • 0 min

Share

Original Source(s)

Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use?

  • by Margarete Teresa Walach, Ralph Burger, Felix Brumm, Katja Nitschke, Frederik Wessels, Philipp Nuhn, Thomas Stephan Worst, Jost von Hardenberg, Britta Grüne, Jonas Jarczyk

  • January 29, 2025

Related Content

Consensus Guidelines for the Management of Locally Advanced and Metastatic Renal Cell Carcinoma by the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology for 2025

Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma

Kidney Cancer Updates - GU Oncology Cancer Highlights: ESMO 2024

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates you need to know from ESMO 2024.

  • November 4, 2024

  • 1 min